PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 54 filers reported holding PROQR THRAPEUTICS N V in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $490,772 | +27.5% | 377,517 | +58.9% | 0.15% | +36.4% |
Q2 2023 | $384,778 | +0.7% | 237,517 | +32.4% | 0.11% | -8.5% |
Q1 2023 | $381,981 | -37.4% | 179,334 | +8.7% | 0.12% | -36.4% |
Q4 2022 | $610,500 | -11.9% | 165,000 | -82.3% | 0.18% | -30.8% |
Q3 2022 | $693,000 | -4.3% | 931,400 | 0.0% | 0.27% | -15.6% |
Q2 2022 | $724,000 | +782.9% | 931,400 | +924.6% | 0.32% | +854.5% |
Q1 2022 | $82,000 | – | 90,900 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |